UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides

Leukemia, 2016-03, Vol.30 (3), p.649-657

2016

Volltextzugriff (PDF)

Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study

Neurology, 2009-10, Vol.73 (17), p.1381-1387

2009

Volltextzugriff (PDF)

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

Leukemia, 2006-06, Vol.20 (6), p.971-978

2006

Volltextzugriff (PDF)

On the TRAIL of a new therapy for leukemia

Leukemia, 2005-12, Vol.19 (12), p.2195-2202

2005

Volltextzugriff (PDF)

Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium

Leukemia, 2017-06, Vol.31 (6), p.1391-1397

2017

Volltextzugriff (PDF)

"Congo" red: out of Africa?

Archives of pathology & laboratory medicine (1976), 2001-02, Vol.125 (2), p.250-252

Steensma, D P

2001

Volltextzugriff (PDF)

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

Leukemia, 2017-11, Vol.31 (11), p.2539-2541

2017

Volltextzugriff (PDF)

Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder

Neurology, 2008-11, Vol.71 (20), p.1644-1645

2008

Volltextzugriff (PDF)

Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia

Leukemia, 2006-10, Vol.20 (10), p.1800-1808

2006

Volltextzugriff (PDF)

Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q

Leukemia, 2009-04, Vol.23 (4), p.796-800

2009

Volltextzugriff (PDF)

Lymphadenopathy

Mayo Clinic proceedings, 2000-07, Vol.75 (7), p.723-732

2000

Volltextzugriff (PDF)

Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1121-1126

2016

Volltextzugriff (PDF)

Sister (Mary) Joseph's nodule

Annals of internal medicine, 2000-08, Vol.133 (3), p.237

Steensma, D P

2000

Volltextzugriff (PDF)

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Haematologica (Roma), 2016-06, Vol.101 (6), p.781-788

2016

Volltextzugriff (PDF)

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2 positive, del(5)(q13q33) myelodysplastic syndrome

Leukemia, 2006-11, Vol.20 (11), p.2063-2064

2006

Volltextzugriff (PDF)

Submitting to autonomy

Journal of clinical oncology, 2000-11, Vol.18 (21), p.3736-3737

Steensma, D P

2000

Volltextzugriff (PDF)

The art and science of prognosis in patients with advanced cancer

European journal of cancer (1990), 2000-10, Vol.36 (16), p.2025-2027

2000

Volltextzugriff (PDF)

The bone-marrow niche in MDS and MGUS: implications for AML and MM

Nature reviews. Clinical oncology, 2018-04, Vol.15 (4), p.219-233

2018

Volltextzugriff (PDF)

Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q

Journal of thrombosis and haemostasis, 2007-03, Vol.5 (3), p.626-628

2007

Volltextzugriff (PDF)

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Science translational medicine, 2018-04, Vol.10 (436)

2018

Volltextzugriff (PDF)

Hereditary Red Blood Cell Disorders in Middle Eastern Patients

Mayo Clinic proceedings, 2001-03, Vol.76 (3), p.285-293

2001

Volltextzugriff (PDF)

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

Blood, 2019-03, Vol.133 (10), p.1020-1030

2019

Volltextzugriff (PDF)

The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

Haematologica (Roma), 2016-06, Vol.101 (6), p.e224-e227

2016

Volltextzugriff (PDF)

Autoimmune Hemolytic Anemia in a Patient With Autosomal Dominant Chronic Mucocutaneous Candidiasis

Mayo Clinic proceedings, 2000-08, Vol.75 (8), p.853-855

2000

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(347)
Mit Volltextzugriff
(326)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(225)
Life Sciences & Biomedicine
(219)
Humans
(194)
Hematology
(87)
Male
(84)
Female
(83)
Biological And Medical Sciences
(64)
Internal Medicine
(64)
General & Internal Medicine
(61)
Medicine, General & Internal
(61)
Medical Sciences
(54)
Oncology
(54)
History, 20th Century
(51)
Middle Aged
(51)
Aged
(49)
Adult
(36)
Hematologic And Hematopoietic Diseases
(35)
Philately
(35)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Myelodysplastic Syndrome
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides

Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study

JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained

On the TRAIL of a new therapy for leukemia

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium

"Congo" red: out of Africa?

Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder

Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia

Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q

Lymphadenopathy

Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

Sister (Mary) Joseph's nodule

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2 positive, del(5)(q13q33) myelodysplastic syndrome

Submitting to autonomy

The art and science of prognosis in patients with advanced cancer

The bone-marrow niche in MDS and MGUS: implications for AML and MM

Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Hereditary Red Blood Cell Disorders in Middle Eastern Patients

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

Autoimmune Hemolytic Anemia in a Patient With Autosomal Dominant Chronic Mucocutaneous Candidiasis

Suchergebnisse filtern